Elion
228 Park Ave South, PMB 33088, New York, NY, 10003, United States
Overview
Elion operates an AI-powered research and intelligence platform and vendor marketplace that aggregates a structured dataset of thousands of healthcare vendors and delivers curated insights for provider decision-makers. The platform combines proprietary vendor and product intelligence with expertise in health-system workflows and decision dynamics to help organizations evaluate solutions. Elion reports strong traction, with over 60% of U.S. health systems using its vendor marketplace and a 5x increase in usage over the past year. The company plans to accelerate platform development, launch new products, and scale its reach across the healthcare technology ecosystem. To support growth it is expanding its team across engineering, research, and marketing. Financially, Elion recently closed an oversubscribed $9.3M seed financing to fund these initiatives. Elion operates a comprehensive vendor marketplace, taxonomy, and tactical content library to help healthcare builders discover, evaluate, and select digital health infrastructure vendors. Its core product includes a taxonomy to structure solution categories, a marketplace for comparing vendors, and in-depth guides and playbooks. The company emphasizes stakeholder-driven insights and practical content to simplify vendor selection and integration decisions. Elion released its beta product to the public and is hiring across product and market insights teams. The business intends to expand its marketplace, accelerate content development, and scale go-to-market efforts using new capital. Founded in 2022 and led by CEO and co-founder Bobby Guelich, Elion positions itself as an independent, authoritative source for digital health vendor selection.
- Total raised
- $13M
- Funding rounds
- 2
- Latest round
- Seed
- Latest activity
- Aug 2025
Industries
- Health Care
- Information Services
- Information Technology
- Software
Recent funding
Seed
Aug 2025
$9M
Seed
Oct 2022
$3M